Mutational spectrum of HBD gene in the Chinese population: Description of 36 mutations including 11 novel variants
International Journal of Laboratory Hematology · 2023
DOI: 10.1111/ijlh.14155 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, 2023. Verfasst von Anping Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China. Hauptthemen laut MEDLINE: beta-Thalassemia, delta-Thalassemia, Hemoglobins, Abnormal. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Department of Science and Technology of Guangdong Province, Guangdong Basic and Applied Basic Research Fund, Guangdong Medical Science Foundation.
Abstract (Originalsprache)
Introduction
Mutations in the hemoglobin subunit delta ( HBD ) gene (MIM#142000) are associated with decreased levels of the Hemoglobin A 2 (Hb A 2 ) fraction. We aimed to examine the prevalence of HBD gene mutations and summarize their characteristics in the Chinese population.
Methods
Individuals who exhibited Hb A 2 levels below 1.8%, with or without Hb A 2 variant peaks, were chosen for further investigation. Hemoglobin analysis was conducted using capillary electrophoresis. Common α and β‐thalassemia in China were detected using gap‐PCR and reverse dot blot hybridization. The presence of HBD gene mutations was confirmed by DNA sequencing.
Results
A total of 188 patients were identified as carriers of the HBD gene mutation, with a prevalence of approximately 0.46%. We discovered 36 types of mutations, 30 of which resulted in δ‐globin variants, while the remaining 6 resulted in δ‐thalassemia. The most common mutation was HBD :c.‐127 T > C, accounting for 87.2% of δ‐thalassemia cases. In addition, we identified 11 novel HBD gene mutations and found 10 cases compounded with other common thalassemias.
Conclusion
We observed a high prevalence of HBD gene mutations in southern China. Our findings provide a genetic basis for screening for δ‐thalassemia and enrich the spectrum of HBD gene mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Peking University Shenzhen Hospital, Shenzhen, China.
- Department of Laboratory Medicine, Shenzhen University General Hospital, Shenzhen, China.
- Department of Laboratory Medicine, Shenzhen Longgang District Sixth People's Hospital, Shenzhen, China.
ORCID-Profile: Anping Xu, Shang Ying Wu
Förderung
- Department of Science and Technology of Guangdong Province
- Guangdong Basic and Applied Basic Research Fund
- Guangdong Medical Science Foundation
- National Natural Science Foundation of China
- Guangdong Provincial Department of Science and Technology
Zitieren
APA
Xu, A., Li, M., Ye, Y., Li, L., Ma, M., Wu, S. Y., & Ji, L. (2023). Mutational spectrum of HBD gene in the Chinese population: Description of 36 mutations including 11 novel variants. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14155
Vancouver
Xu A, Li M, Ye Y, Li L, Ma M, Wu SY, et al. Mutational spectrum of HBD gene in the Chinese population: Description of 36 mutations including 11 novel variants. International Journal of Laboratory Hematology. 2023. doi:10.1111/ijlh.14155
BibTeX
@article{Xu2023,
author = {Xu, Anping and Li, Mingyang and Ye, Yinghui and Li, Liping and Ma, Minjing and Wu, Shang Ying and Ji, Ling},
title = {Mutational spectrum of HBD gene in the Chinese population: Description of 36 mutations including 11 novel variants},
journal = {International Journal of Laboratory Hematology},
year = {2023},
doi = {10.1111/ijlh.14155}
}
EUVIMED